Goldman Sachs Group Inc Regenxbio Inc. Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Regenxbio Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 756,238 shares of RGNX stock, worth $5.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
756,238
Previous 743,387 1.73%
Holding current value
$5.5 Million
Previous $7.8 Million 25.04%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$7.23 - $11.56 $92,912 - $148,557
12,851 Added 1.73%
756,238 $5.85 Million
Q3 2024

Nov 14, 2024
BUY
$10.49 - $14.39 $987,570 - $1.35 Million
94,144 Added 14.5%
743,387 $7.8 Million
Q2 2024

Aug 13, 2024
SELL
$11.51 - $21.53 $855,906 - $1.6 Million
-74,362 Reduced 10.28%
649,243 $7.6 Million
Q1 2024

May 15, 2024
BUY
$12.17 - $24.61 $4.72 Million - $9.54 Million
387,499 Added 115.29%
723,605 $15.2 Million
Q4 2023

Feb 13, 2024
SELL
$12.89 - $20.82 $3.36 Million - $5.43 Million
-260,748 Reduced 43.69%
336,106 $6.03 Million
Q3 2023

May 14, 2024
BUY
$16.46 - $19.99 $4.29 Million - $5.21 Million
260,748 Added 77.58%
596,854 $9.82 Million
Q3 2023

Nov 14, 2023
BUY
$16.46 - $19.99 $277,762 - $337,331
16,875 Added 2.91%
596,854 $9.82 Million
Q2 2023

May 14, 2024
BUY
$17.23 - $21.71 $400,907 - $505,148
23,268 Added 4.18%
579,979 $11.6 Million
Q2 2023

Aug 14, 2023
BUY
$17.23 - $21.71 $400,907 - $505,148
23,268 Added 4.18%
579,979 $11.6 Million
Q1 2023

May 14, 2024
SELL
$18.08 - $24.55 $718,806 - $976,034
-39,757 Reduced 6.67%
556,711 $10.5 Million
Q1 2023

May 11, 2023
SELL
$18.08 - $24.55 $718,806 - $976,034
-39,757 Reduced 6.67%
556,711 $10.5 Million
Q4 2022

May 14, 2024
SELL
$20.4 - $24.73 $707,778 - $858,007
-34,695 Reduced 5.5%
596,468 $13.5 Million
Q4 2022

Feb 13, 2023
SELL
$20.4 - $24.73 $707,778 - $858,007
-34,695 Reduced 5.5%
596,468 $13.5 Million
Q3 2022

May 14, 2024
BUY
$22.29 - $35.04 $2.92 Million - $4.59 Million
131,038 Added 26.2%
631,163 $16.7 Million
Q3 2022

Nov 10, 2022
BUY
$22.29 - $35.04 $2.92 Million - $4.59 Million
131,038 Added 26.2%
631,163 $16.7 Million
Q2 2022

May 14, 2024
BUY
$19.35 - $35.04 $3.17 Million - $5.75 Million
164,019 Added 48.8%
500,125 $12.4 Million
Q2 2022

Aug 15, 2022
BUY
$19.35 - $35.04 $7.37 Million - $13.4 Million
381,047 Added 320.0%
500,125 $12.4 Million
Q1 2022

May 16, 2022
SELL
$24.62 - $34.31 $4.94 Million - $6.88 Million
-200,469 Reduced 62.74%
119,078 $3.95 Million
Q4 2021

Feb 14, 2022
SELL
$30.19 - $40.28 $1.71 Million - $2.29 Million
-56,795 Reduced 15.09%
319,547 $10.4 Million
Q3 2021

Nov 10, 2021
BUY
$29.09 - $45.68 $10.9 Million - $17.2 Million
376,342 New
376,342 $15.8 Million

Others Institutions Holding RGNX

# of Institutions
191
Shares Held
45.4M
Call Options Held
184K
Put Options Held
56.7K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $314M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email